SURVYR

DHR

Danaher Corporation
$234.07
+$2.07 (0.89%)Oct 28 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-27%-16%-6%+5%+15%Oct 2025Oct 2026Apr 202652w high $242.8052w low $160.93
DHRSPY
Wall St. Highest PT $310.00 (+32.4%) Wall St. Avg PT $247.18 (+5.6%)
$161$201$240$280$319POC $221Hi $310Avg $247
Underwater Drawdown %Max DD -33.0%Current -2.7%
0.0%-33.0%
Relative Strength vs SPY-7.2% vs SPYUnderperforming
+40%0%-40%
1W
+$0.21 (0.09%)
1M
+$7.14 (3.15%)
3M
+$37.93 (19.34%)
6M
+$55.96 (31.42%)
YTD
+$6.51 (2.86%)
1Y
+$18.76 (8.71%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Strong Buy
22 analysts · mean score 1.48
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$234.07
Average target$247.18
+$13.11 (+5.6%) upsideaverage target vs current price
CurrentAverageMedian
Low$200.00
Median$247.18
High$310.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$164.4B
P/E (last 12 months)41.7
P/E (next 12 months, estimated)25.1
52-week range$160.93 – $242.80
Revenue growth (latest quarter vs a year ago)+5.5%
Dividend yield0.71%
Analyst consensusStrong Buy (22)
Average analyst price target$247.18 (+6%)

What they do

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate.

Healthcare · Diagnostics & Research
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
35th percentile in sector
C-
12-1 return: +3.6%
Percentile within its GICS sector across the S&P 1500.
Growth
32nd percentile in sector
D+
Revenue growth (YoY): +5.5%
Percentile within its GICS sector across the S&P 1500.
Value
27th percentile in sector
D+
Forward E/P: 4.1% · EBITDA/EV: 4.4%
Percentile within its GICS sector across the S&P 1500.
Profitability
58th percentile in sector
B-
Profit margin: +15.9% · Return on equity: +7.6%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 268 of 499 · 12-month momentum 8.3%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

DHR earningsReported Oct 21, 2026▲ Above estimates
Results · Before the open
EPS actual$2.11
EPS estimate$1.92
Surprise+10.0%
RevenueNot in our data yet

Revenue for this quarter is not in our data yet. It arrives with the quarterly filing.

Next report
Wed Jan 27, 2027Before the open
EPS consensus$2.48
Revenue consensus–
Last 4 quarters · EPS vs estimate
Oct 21, 2026$2.11est $1.92+10.0%Above estimates
Jul 21, 2026$1.94est $1.84+5.3%Above estimates
Apr 21, 2026$2.06est $1.94+6.5%Above estimates
Jan 28, 2026$2.23est $2.19+2.0%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-27 17:57:04 ET
25-0125-0425-0725-1026-0126-0426-0726-100.002.23
EstimateActual (beat)Actual (miss)

News & catalysts

More news
Company News for Oct 22, 2026
Zacks · Oct 22
Why Danaher Stock Bounced Higher Today
Nasdaq · Oct 21
Danaher: 3 Key Takeaways for Long-Term Investors
Nasdaq · Oct 21
Danaher (DHR) Q3 2026 Earnings Call Transcript
Nasdaq · Oct 21
Danaher Q3 26 Earnings Conference Call At 8:00 AM ET
Nasdaq · Oct 21
Insider trades
Blair Rainer
Director, President & CEO · 2026-08-21
Sell
$1.7M
Blair Rainer
Director, President & CEO · 2026-08-21
Sell
$8.6M
Blair Rainer
Director, President & CEO · 2026-08-21
Sell
$2.5M
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 17:57:04 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026